News on Approval of a Non-Stimulant ADHD Medication and More

From development of nasal spray to treat dry eye disease to approval of the first Alzheimer's disease treatment in nearly 20 years, learn about the most impactful changes at each stage of the drug pipeline in this edition of Perspective on the Rx Pipeline.

Perspective on the Rx Pipeline

Clinical Pipeline

Within the extensive pipeline of drugs preparing for market launch, these are the three most notable drugs plan sponsors should be aware of:

Drug Approvals

Six drugs recently approved by the FDA include:

New Indications

Drugs that have gained FDA approval for the treatment of additional diseases and/or conditions and have potential to be impactful include:

Generic Approvals

There are several new generic product offerings to the marketplace, including drugs for the treatment of multiple sclerosis, HIV and diabetes. A review of generic launches, including biosimilars, is provided in the full report.

Download the full report for more information, including important safety updates and drug shortages and discontinuations.